About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
Jun 03, 2020...
Israeli government investment arm the Israel Innovation Authority (IIA) has approved the establishment of the CRISPR-IL consortium, which will focus on the integration of artificial intelligence (AI) and CRISPR technologies to develop advanced computational tools for genome editing, IIA announced Wednesday.
The consortium will be allocated with a total of NIS 36 million (approximately $10.36 million) for a period of 18 months, with an option to extend operations for an additional 18 months.
Jul 29, 2020... REHOVOT, ISRAEL—July 29, 2020—The Weizmann Institute of Science and Schneider Children’s Medical Center of Clalit Health Services signed a Memorandum of Understanding today on a collaborative biomedical research initiative. The “Schneider-Weizmann Center for Research on Child and Adolescent Health” will be jointly established by the two entities. The anticipated fields of research include oncology, neurology, psychiatry, gastroenterology, endocrinology, nutrition, and metabolism. Other fields of research may be agreed upon in the future.
Sep 13, 2020... REHOVOT, ISRAEL—September 13, 2020—A Memorandum of Understanding (MoU) between the Weizmann Institute of Science in Israel and the Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) in the United Arab Emirates was signed on September 12. The signing ceremony, which was held virtually, took place in the presence of Weizmann Institute President Prof. Alon Chen and His Excellency Dr. Sultan Ahmed Al Jaber, Minister of Industry and Advanced Technology, member of the Federal Cabinet, and Chairman of the MBZUAI Board of Trustees. A delegation headed by President Chen is expected to travel to Abu Dhabi next week to finalize the details of the MoU and discuss its implementation.
Sep 16, 2020... REHOVOT, ISRAEL—September 16, 2020—By tracking the evolution of what may be our oldest means of fighting off viral infection, a group at the Weizmann Institute of Science has uncovered a gold mine of antiviral substances that may lead to the development of highly effective antiviral drugs. These substances are made by virus-fighting enzymes known as viperins, which were previously known to exist only in mammals and have now been found in bacteria. The molecules produced by the bacterial viperins are currently undergoing testing against human viruses such as influenza and COVID-19. The study was published in Nature.
Feb 04, 2021... American Committee CEO Dave Doneson shares news of the Weizmann Institute’s historic partnership with Mohamed bin Zayed University of Artificial Intelligence in the UAE. In a first-of-its-kind undertaking, the two institutions will work together to significantly advance AI research, including through student and postdoc exchanges, conferences and seminars, research collaborations, and a joint virtual institute for AI. The partnership will also support Weizmann’s Artificial Intelligence Enterprise for Scientific Discovery, a flagship initiative that will harness the power of AI to transform biomedicine, environmental research, and other areas of science.
Feb 24, 2021... REHOVOT, ISRAEL—February 24, 2021—Following the Memorandum of Understanding signed by Israel’s Weizmann Institute of Science (WIS) and the United Arab Emirates’ Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) in September 2020, the two institutions have announced the establishment of the WIS-MBZUAI Joint Program for Artificial Intelligence Research. The new program will promote collaborative initiatives in fundamental artificial intelligence (AI) research and will explore AI applications in domains such as healthcare, genomics, and more.
©2022 American Committee for the Weizmann Institute of Science
